Head & Neck Cancer

Latest News

Adding avelumab to VEGFR inhibitor axitinib may prolong survival and improve outcomes among patients with recurrent/metastatic adenoid cystic carcinoma.
Axitinib Plus Avelumab Yields Some Responses in Adenoid Cystic Carcinoma

March 29th 2023

Adding avelumab to VEGFR inhibitor axitinib may prolong survival and improve outcomes among patients with recurrent/metastatic adenoid cystic carcinoma.

HPV Testing, p16 IHC May be Needed for Oropharyngeal Cancer Trials | Image Credit: © CLIPAREA.com - stock.adobe.com.
HPV Testing, p16 IHC May be Needed for Oropharyngeal Cancer Trials

March 22nd 2023

Camrelizumab plus apatinib demonstrate impressive anti-tumor activity in a pretreated population with recurrent or metastatic nasopharyngeal carcinoma, although further research is needed, according to an expert from Memorial Sloan Kettering Cancer Center.
Camrelizumab Yields ‘Impressive’ Activity in Head & Neck Cancer Subtype

March 7th 2023

Data from the phase 3 ROMAN trial and the phase 2b GT-201 trial support the new drug application for avasopasem for radiotherapy-induced severe oral mucositis in those with head and neck cancer.
FDA Grants Priority Review to Avasopasem for Treatment-Related Oral Mucositis

February 15th 2023

Findings from a randomized clinical trial suggest that tele-cognitive behavioral therapy may help reduce body image distress among survivors of head and neck cancer.
Tele-Cognitive Therapy May Improve Body Image Distress in Head and Neck Cancer Survivors

February 1st 2023

More News

Commentary (Goodwin): Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer

W. Jarrard Goodwin, MD, FACS
June 1st 1995

Management of the neck lymph nodes is a critical factor in the success of treatment for patients with malignant head and neck tumors. Recurrence in the neck is an important cause of treatment failure, second in frequency only to recurrence at the primary site [1,2].

Commentary (Schuller): Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer

David E. Schuller, MD
June 1st 1995

Dr. Stringer has done an excellent job of reviewing the anatomic, biologic, diagnostic, and therapeutic considerations that impact on the management of nodal metastases from head and neck malignancies. This is a thorough summary of the current

Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer

Scott P. Stringer, MD
May 31st 1995

This article will address modified, selective, and radical neck dissection as well as other surgical considerations, and will review the surgical techniques currently available for neck treatment.

<1
...
1213141516